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Infections due to different genospecies of the
Acinetobacter calcoaceticus-A baumannii complexDear Editor,
We read with great interest the article by Chang et al in the
December issue of the Journal of the Formosan Medical
Association.1 In that report, the authors retrospectively
investigated 180 adults with ventilator-associated pneu-
monia (VAP) caused by Acinetobacter baumannii. Of the
180 A baumannii isolates, 87 (48.3%) were susceptible to
imipenem. The authors also reported several significant
differences in terms of score on the Charlson Comorbidity
Index, site of infection, white blood cell count, and in-
hospital mortality rate between patients with VAP caused
by imipenem-resistant A baumannii and patients with VAP
caused by imipenem-susceptible A baumannii. Their find-
ings are interesting, however, no molecular methods were
used to identify isolates of Acinetobacter at the genospe-
cies level. In addition, the authors did not investigate the
clinical association between different A baumannii geno-
species and the development of VAP.
Acinetobacter genospecies 1 (A calcoaceticus), genospe-
cies 2 (A baumannii), genospecies 3 (A pittii), and geno-
species 13TU (A nosocomialis) are phenotypically similar and
are, therefore, difficult to differentiate using conventional
laboratory methods.2e4 Ko et al proposed that the three
genospecies be referred to as the A calcoaceticus-A bau-
mannii complex (ACB complex).2 Recent reports, however,
have clearly demonstrated that there are significant varia-
tions in their antimicrobial susceptibility profiles, clinical
features, and the clinical outcomes of patients with
bacteremia due to A baumannii, Acinetobacter genospecies
13TU, and Acinetobacter genospecies 3.2,5 For example,
antimicrobial susceptibility testing of the clinical isolates
from patients with bacteremia due to the ACB complex
revealed that A baumannii isolates (nZ 221; 75.9%) are less
susceptible to antimicrobial agents than Acinetobacter
genospecies 3 (n Z 67; 23.0%).2 The results of the antimi-
crobial susceptibility testing also demonstrated that all
isolates of Acinetobacter genospecies 3 are susceptible to
ampicillin-sulbactam and imipenem. In contrast, 67% of the0929-6646/$ - see front matter Copyright ª 2012, Elsevier Taiwan LLC
doi:10.1016/j.jfma.2012.01.011A baumannii isolates are susceptible to ampicillin-sulbactam
and 90% of isolates are susceptible to imipenem.2
Another study on the 215 isolates of the ACB complex that
are associated with bacteremia found that the rates of
multidrug resistance and carbapenem resistance are higher
among A baumannii isolates than among Acinetobacter
genospecies 13TU or Acinetobacter genospecies 3 isolates
(p < 0.001).5 In addition, bacteremia due to A baumannii
(nZ 117; 54.4%) is associated with a higher 14-day mortality
rate (p < 0.001), a higher 30-day mortality rate (p < 0.001),
and a higher in-hospital mortality rate than bacteremia due
to Acinetobacter genospecies 13TU (n Z 77; 35.8%) or Aci-
netobacter genospecies 3 (n Z 21; 9.8%).5 Bacteremia
caused by multidrug-resistant A baumannii isolates tend to
be associated with poor clinical outcomes (p Z 0.069). In
addition, molecular epidemiological analysis of the isolates
showed that there was no clonal spread of Acinetobacter
genospecies 13TU or Acinetobacter genospecies 3.5
In conclusion, it is important to perform molecular
studies in order to differentiate between different geno-
species of the ACB complex and to understand the clinical
association between different A baumannii genospecies
and the development of VAP.
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